Inventor · disambiguated record
Gurunadh Reddy Chichili
Also filed as: CHICHILI GURUNADH REDDY
7 granted patents·5 pending applications·96 citations·filing 2014–2023
85Inventor score
Files withMACROGENICS INC12
Top patents by PatentIndex Score
12 records- 0197US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0294US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 0394US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 0489US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 0588US10954301B2Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 23, 2021·3 cites·8 claims
- 0685US2024182559A1MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENSMACROGENICS INC·Filed 2023·Application pending·0 cites
- 0783US11820818B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2020·Granted Nov 21, 2023·1 cites·16 claims
- 0880US2024084015A1Methods of using bispecific molecules having immunoreactivity with pd-1 and ctla-4MACROGENICS INC·Filed 2023·Application pending·0 cites
- 0973US11840571B2Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4MACROGENICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 1072US2024043537A1Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of DiseaseMACROGENICS INC·Filed 2023·Application pending·0 cites
- 1165US2021047426A1Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses ThereofMACROGENICS INC·Filed 2020·Application pending·0 cites
- 1240US2019002563A1Bispecific Monovalent Diabodies That are Capable of Binding B7-H3 and CD3, and Uses ThereofMACROGENICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →